Limited value of cabergoline in Cushing's disease: a prospective study of a 6-week treatment in 20 patients.

Research output: Contribution to journalArticle

Bibtex

@article{a4fbd21b71b6470b9c5ceefc99a67e32,
title = "Limited value of cabergoline in Cushing's disease: a prospective study of a 6-week treatment in 20 patients.",
abstract = "The role of cabergoline in Cushing's disease (CD) remains controversial. The experience is limited to case reports and few open studies that report the effects determined after ≥1 month of treatment. In prolactinomas and dopamine-responsive GH-secreting tumours, effects of cabergoline are seen within days or weeks. Here, we searched for short-term effects of cabergoline in CD.",
author = "Pia Burman and Britt Ed{\'e}n-Engstr{\"o}m and Bertil Ekman and Karlsson, {F Anders} and Erik Schwarcz and Jeanette Wahlberg",
year = "2016",
doi = "10.1530/EJE-15-0807",
language = "English",
volume = "174",
pages = "17--24",
journal = "European Journal of Endocrinology",
issn = "1479-683X",
publisher = "Society of the European Journal of Endocrinology",
number = "1",

}